Patient and Caregiver
Investigator
Regulator
IRB
Tech, Device,
PayerTrial Design Stage
Published Date: April 29, 2025
Share to:
Helpful Terms and Definitions
Final Protocol
Questions To Ask
- What measures should be in place to protect participants' data privacy and confidentiality?
- What is the process for submitting my protocol, and what documentation is required?
- What are the IRB's requirements for monitoring participant safety and reporting adverse events?
- How will feedback be provided, and what is the process for addressing any requested revisions?
Why involve IRBs now?
At this stage, sponsors prepare the protocol package for official IRB review and engage investigators and sites to ensure readiness for activation.
Helpful actions at this stage:
- Submit the final protocol and all required documents to the appropriate IRB(s).
- Respond promptly to IRB questions, requests for clarification, or stipulations.
- Ensure the informed consent form is clear, written in plain language, and contextually appropriate for the participant population.
- Finalize risk mitigation strategies and safety reporting plans.
- Maintain complete documentation of the review process.
Engaging investigators and sites:
- Distribute the final protocol and schedule study kick‑off meetings.
- Train sites on clinical assessments, technology systems, safety reporting, and study procedures.
- Communicate expectations clearly (e.g., timelines, data entry, recruitment goals).
- Share any protocol amendments through open, timely communication.
The final IRB approval marks the transition from planning to implementation, with ongoing responsibilities for reporting deviations, amendments, and continuing review.
What aspects of the study concept should they inform?
- Study Design
- Informed Consent
- Risk/Benefit Analysis
- Participant Selection
- Data Collection and Privacy
- Safety Monitoring
- Regulatory Compliance